Found: 16
Select item for more details and to access through your institution.
Strong CD4<sup>+</sup> T-Cell Responses to Ancestral and Variant Spike Proteins Are Established by NVX-CoV2373 Severe Acute Respiratory Syndrome Coronavirus 2 Primary Vaccination.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 6, p. 734, doi. 10.1093/infdis/jiad163
- By:
- Publication type:
- Article
901. MEDI8897 Prevents Serious RSV Disease in Healthy Preterm Infants.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S27, doi. 10.1093/ofid/ofz359.060
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Live Attenuated RSV Vaccine in Healthy RSV-Seronegative Children 5 to 24 Months of Age.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077104
- By:
- Publication type:
- Article
Safety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials.
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013755
- By:
- Publication type:
- Article
Blood Stage Malaria Vaccine Eliciting High Antigen- Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya.
- Published in:
- PLoS ONE, 2009, v. 4, n. 3, p. 1, doi. 10.1371/journal.pone.0004708
- By:
- Publication type:
- Article
Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial.
- Published in:
- Trials, 2007, v. 8, p. 11, doi. 10.1186/1745-6215-8-11
- By:
- Publication type:
- Article
Safety and Reactogenicity of an MSP-1 Malaria Vaccine Candidate: A Randomized Phase Ib Dose-Escalation Trial in Kenyan Children.
- Published in:
- PLoS Clinical Trials, 2006, v. 3, n. 11, p. 0001
- By:
- Publication type:
- Article
RTS,S/AS02A Malaria Vaccine Does Not Induce Parasite CSP T Cell Epitope Selection and Reduces Multiplicity of Infection.
- Published in:
- PLoS Clinical Trials, 2006, v. 3, n. 5, p. 1, doi. 10.1371/journal.pctr.0010005
- By:
- Publication type:
- Article
A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 676, p. 1, doi. 10.1126/scitranslmed.ade0424
- By:
- Publication type:
- Article
The safety and efficacy of quadrivalent live attenuated influenza vaccine in Japanese children aged 2‐18 years: Results of two phase 3 studies.
- Published in:
- Influenza & Other Respiratory Viruses, 2018, v. 12, n. 4, p. 438, doi. 10.1111/irv.12555
- By:
- Publication type:
- Article
Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study.
- Published in:
- Influenza & Other Respiratory Viruses, 2013, v. 7, n. 6, p. 1142, doi. 10.1111/irv.12027
- By:
- Publication type:
- Article
Quantitative Detection of Plasmodium falciparum DNA in Saliva, Blood, and Urine.
- Published in:
- Journal of Infectious Diseases, 2009, v. 199, n. 11, p. 1567, doi. 10.1086/598856
- By:
- Publication type:
- Article
Heterogeneous virulence of enteroaggregative Escherichia coli strains isolated from children in Southwest Nigeria.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial.
- Published in:
- PLoS Medicine, 2021, v. 18, n. 10, p. 1, doi. 10.1371/journal.pmed.1003769
- By:
- Publication type:
- Article
Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e239135, doi. 10.1001/jamanetworkopen.2023.9135
- By:
- Publication type:
- Article
An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults.
- Published in:
- 2017
- By:
- Publication type:
- journal article